Please Wait...

David Scott

Translation skills

Main profile

David Scott, PhD

David Scott is a Scientist at BioClinica with experience utilizing neuroimaging techniques to study the neural correlates of behavior and centrally-mediated diseases such as chronic pain, depression, and addiction, with a recent emphasis on Alzheimer's Disease and Stroke.  In his current position, David collaborates with pharma and academic specialists in the application of medical imaging to answer clinically and scientifically important questions in the evaluation of drug efficacy and safety.

As a student at Johns Hopkins University and the University of Michigan, he employed multi-modal imaging approaches including functional PET and fMRI to study the neurobiology of placebo analgesia.  As a Research Scientist at Omneuron, he developed real-time fMRI applications aimed at treating chronic diseases, and employed advanced MRI-based tools including voxel-based morphometry, spectroscopy, diffusion tensor imaging, arterial spin labeling, resting-state and task-based fMRI to identify a brain-based biomarker for chronic pain.  David has employed these tools in multiple clinical trials, involving thousands of scan hours in hundreds of patients and healthy controls.


Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

In case you missed it: Bioclinica announces additions to Software Solutions leadership. We welcome Guy Crossley, Ri…
Bioclinica (6 days ago)
Meet Chief Science Officer, Thomas Fuerst, Ph.D., to learn more about our musculoskeletal imaging services.…
Bioclinica (1 week ago)
Going to SCOPE? Visit Bioclinica at booth 404! #SCOPE2020
Bioclinica (2 weeks ago)
We’re heading to #JPM2020, are you? Reach out if you’d like to learn how Bioclinica partners with sponsors to advan…
Bioclinica (2 weeks ago)
Meet Chief Medical Officer, Michael O'Neal M.D., to learn more about our oncology imaging services.…
Bioclinica (3 weeks ago)
Are there risks in your clinical trial supply chain? Learn more here
Bioclinica (3 weeks ago)